Page 42 - Codexis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biofuel Enzymes Market Demand And Industry Challenges During Covid-19 2022 | 2022-03-28 09:46:13

Taylor Frigon Capital Management LLC trimmed its stake in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 18.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 199,868 shares of the biotechnology company’s stock after selling 45,106 shares during the quarter. Codexis accounts for about 2.0% of Taylor Frigon Capital Management LLC’s holdings, making the stock […]

Codexis, Inc. (NASDAQ:CDXS – Get Rating) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $16.48 and last traded at $16.55, with a volume of 4714 shares changing hands. The stock had previously closed at $16.97. Several brokerages have recently issued reports on CDXS. TheStreet lowered […]

Popular stock picker Cathie Wood's Ark Investment Management on Thursday stayed away from buying more shares in favorite stocks on the di...

DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology: Global Markets" report has been added to ResearchAndMarkets.com's offering.The study scope includes core synthetic biology products (e.g., oligonucleotides, synthetic genes, BioBrick parts, delivery plasmids, chassis organisms, synthetic cells, cell-based and cell-fre...